Highly EZH2 protein expression level is also associated with the early pathogenesis and prognosis of NSCLC patients, and promotes tumor progression via regulating VEGF-A/AKT signaling [34]. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.